Font Size: A A A

COVID-19 Vaccine Planning

COVID-19 vaccine planning

This is a centralized resource where you'll find everything you need to know to be ready to administer COVID-19 vaccine. We’ll regularly update this page as more information is available. 

Social media resources


Download a Profile Image for Social Media

Download a Sign for Photos/Posting in your Workplace
Editable Word Doc - add an organization logo
Editable Word Doc - Spanish
PDF - Spanish

Nevada resources

Videos, Flyers, Multiple Language Resources

From Concern to Confidence - How Physicians Can Build Trust in COVID-19 Vaccines

Technical bulletins
Access all bulletins

Janssen COVID-19 vaccine

Janssen COVID-19 Vaccine Fact Sheet for Healthcare Providers

Janssen COVID-19 Fact Sheet for Patients

Fact Sheet on Vaccines and Fetal Cell Lines (Immunize Nevada)

Fact Sheet on Janssen Vaccine (Immunize Nevada)

ACIP Recommendation for Use of Janssen COVID-19 Vaccine

Janssen Vaccine Storage and Handling Summary

Janssen Vaccine Storage and Handling Labels

Transport Guidance Summary

Transport Temperature Log

Janssen Standing Orders

Janssen Training Module

Janssen Preparation and Administration Summary

Pfizer-BioNTech and Moderna resources

What Clinic Personnel Need to Know

Interim Considerations: Preparing for the Potential Management of Anaphylaxis After COVID-19 Vaccination

Screening Form

Interim Clinical Considerations for Use of mRNA COVID-19 Vaccines

Moderna COVID-19 vaccine

Moderna Vaccine Storage and Handling Summary

Moderna Training Module

Moderna Preparation and Administration Summary

Moderna Vaccine Lot 41L20A Technical Bulletin

Moderna COVID-19 Vaccine Information

Moderna COVID-19 Vaccine Standing Orders

Moderna COVID-19 Vaccine Fact Sheet for Healthcare Providers

Moderna COVID-19 Vaccine Fact Sheet for Patients
Moderna COVID-19 Vaccine Fact Sheet for Patients - Translation in 6 languages

Pfizer-BioNTech vaccine

Pfizer-BioNTech Storage and Handling Summary

Pfizer-BioNTech Training Module

Pfizer-BioNTech Preparation and Administration Summary

Pfizer- BioNTech Storage and Handling Checklist

Pfizer-BioNTech Vaccine Information

Pfizer-BioNTech Vaccine Standing Orders

Pfizer-BioNTech COVID-19 Vaccine EUA Fact Sheet for Healthcare Providers

Pfizer-BioNTech COVID-19 Vaccine EUA Fact Sheet for Patients
Pfizer-BioNTech COVID-19 Vaccine EUA Fact Sheet for Patients - Translation in 20 languages

CDC resources

COVID-19 Prevaccination Checklist

Long-Term Care Facility Toolkit: Preparing for COVID-19 Vaccination at Your Facility

CDC COVID-19 Vaccination Program Provider Requirements and Support

COVID-19 Vaccination Communication Toolkit for Medical Centers, Clinics, and Clinicians

10 Things Healthcare Professionals Need to Know

Hosting Mass Immunization Clinics

COVID-19 ACIP Vaccine Recommendations

VaccineFinder Reporting and Finder System

Answering Patients' Questions

Vaccine administration and other resources

Standing Orders and Screening Checklist

Satellite, Temporary, and Off-Site Vaccination Clinic Supply Checklist

Vaccine Storage and Handling with COVID-19 Vaccine Addendum

COVID-19 Vaccine Training Modules

Clinical Training and Resources for Healthcare Professionals

Fever and Vaccines

COVID-19 Vaccine Training through TRAIN

Vaccine Administration Job Aids

Covid Vaccine for Children Under 5: Pediatric Provider FAQs

Billing and coding resources

Payor information for COVID-19 vaccine for immunocompromised individuals

COVID-19 Vaccine Toolkit for Health Insurance Issuers and Medicare Advantage Plan Payers (PDF)

COVID-19 Vaccine Policies and Guidance - CMS

CPT Code set for Coronavirus Immunizations

HRSA COVID-19 Claims Reimbursement - Uninsured Patient Program

Specific Insurance Plan Guidance

Frequently asked questions

COVID-19 Vaccine Development

What is the FDA’s role in approving vaccines and what is being done to produce a COVID-19 vaccine?

The FDA regulates vaccines. Vaccines undergo a rigorous review of laboratory and clinical data to ensure the safety and effectiveness of these products. Approved vaccines may also be required to undergo additional studies to further evaluate the vaccine and often to address specific questions about the vaccine's safety, effectiveness, or possible side effects. The FDA is expediting clinical trials for vaccines by providing timely advice to and interactions with vaccine developers. The FDA is also supporting product development and scaling up of manufacturing capacity for high priority vaccines for COVID-19.

COVID-19 Vaccine Distribution

How does a facility receive COVID-19 Vaccine distribution?

If you are interested in stocking and administering the COVID-19 vaccine and meet the requirements below, please fill out this survey

  • You are enrolled in NV WEBIZ.
  • You have a stand-alone freezer and a stand-alone refrigerator with digital temperature monitoring devices for vaccine storage.

How does a facility request a data logger?

If a facility needs a data logger, they should include their request in the REDCap enrollment survey.  Requests for new data loggers may be submitted to

COVID-19 Vaccine Information

How many doses of COVID-19 vaccine will be needed?

All but one of the COVID-19 vaccines currently in phase 3 clinical trials in the United States use two doses. The other COVID-19 vaccine uses one dose. When giving two doses, they are usually given one or two months apart. We will need to wait for the results of the clinical trials to have more information about how many doses will be needed. 

How do we know the COVID-19 vaccine will be safe?

Independent advisory committees to the Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC) review vaccine safety and effectiveness data before any vaccine is approved or allowed for distribution under Emergency Use Authorization. Vaccines will not be released for use until deemed safe and effective by these committees. In order to speed up the distribution process, Operation Warp Speed is manufacturing vaccines while they are in clinical trials with the intention of throwing them away if the vaccine is not deemed safe and effective at the conclusion of the clinical trial. 

Will COVID-19 vaccines contain a microchip?

COVID-19 vaccines will not contain microchips. This idea is based on a false narrative and misinformation campaign being waged online. 

Will COVID-19 vaccines alter people’s DNA?

No. There is no evidence the vaccines would alter any part of your genomic DNA. These vaccines are “mRNA” vaccines, which use a fragment of genetic material from the virus rather than a weakened or killed version of the virus, to produce an immune response

Since this vaccine is producing an immune response, would someone who received the vaccine then also test positive for COVID-19?

No. A COVID-19 vaccine administration will NEVER yield a positive COVID PCR test result, regardless if a patient has a low-grade fever or not. The vaccine makes the muscle cells produce the spike protein and antibodies are formed to the spike protein. For a test to be positive, there must be viral RNA in the nose. The vaccine does not cause that.

How long is received vaccine viable for? Can vaccine vials be refrigerated after they have been thawed out?

Once vaccine vials have been pulled out of their Ultra-Cold Storage Units, they are viable for up to 5 days in refrigerators. The ultra-cold vaccine, Pfizer product, vials cannot be refrozen. They must only be thawed out with the intention of using them within 5 days of removal from the ultra-cold freezer. Once a vial has been diluted it must be used within 6 hours

COVID-19 Vaccine Reporting

How often must vaccination data be reported?

Vaccination data should ideally be reported within 24 hours, but no later than 72 hours.